ROSELAND, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCQB:EMIS) announced today that Management will host a conference call on Wednesday, August 12, 2015, at 8:30 AM ET to discuss the Company's financial and operational results for the second quarter ended June 30, 2015.
The live webcast of the conference call can be accessed through the Company's website at www.emisphere.com. The call can also be accessed by dialing (877) 303-9483 (United States and Canada) or (760) 666-3584 (international), and entering Conference ID# 4161728. In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning Wednesday, August 12, 2015, at 11:30 am Eastern Time through 11:59 pm Eastern Time on September 1, 2015, by calling (855) 859-2056 (United States and Canada) or (404) 537-3406 (International), and entering Conference ID# 4161728.
Emisphere is a specialty pharmaceutical company that has commenced commercial operations. The Company has launched its first prescription product, oral Eligen B12™, in the U.S. Beyond Eligen B12™, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
CONTACT: COMPANY CONTACTS: Alan L. Rubino, CEO 973.532.8000 email@example.com Michael R. Garone, CFO 973.532.8005 firstname.lastname@example.org INVESTOR CONTACT: Susan Kim Argot Partners (212) 600-1902 email@example.com
Source:Emisphere Technologies, Inc.